Free Trial

Boston Scientific (BSX) News Today

Boston Scientific logo
$101.36 -0.37 (-0.36%)
Closing price 06/18/2025 03:59 PM Eastern
Extended Trading
$101.52 +0.16 (+0.15%)
As of 06/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Why is Boston Scientific Down Today?

Boston Scientific Corporation (NYSE:BSX) is trading higher today following a series of bullish analyst actions and upbeat business updates.

  • Leerink Partners initiated coverage on BSX with a “Strong-Buy” rating and upgraded the stock, signaling confidence in the company’s growth prospects.
  • Leerink Partners raised its FY2025 EPS estimate to $2.93 (consensus $2.85) and set multi-year EPS targets through FY2029, underscoring expected long-term earnings growth.
  • The same firm projects Q2 2025 EPS of $0.73, paired with continued quarterly and annual EPS increases through FY2027, reinforcing the favorable earnings trajectory.
  • Boston Scientific’s neuromodulation unit posted 6.8% revenue growth in Q1, driven by strong pain-management and brain-therapy product sales.
  • Brokers offered varied forecasts for BSX’s Q2 earnings, reflecting a range of expectations ahead of the company’s upcoming report.
  • An industry comparison versus Intuitive Surgical noted BSX’s broader exposure and steady growth profile, even as robotics names face margin and tariff headwinds.
  • A preview of Boston Scientific’s Q1 earnings call highlighted analysts’ top questions on product pipelines, regulatory outlook and margin trends without revealing any major surprises.

Investor takeaway: Upgrades and robust forecasts from a leading health-care analyst, along with solid underlying growth in key surgical and neuromodulation lines, are driving positive sentiment around BSX shares.

Posted 5h agoAI Generated. May Contain Errors.

BSX Latest News

FY2025 Earnings Estimate for BSX Issued By Leerink Partnrs
Boston Scientific Corporation stock logo
Trifecta Capital Advisors LLC Purchases 4,456 Shares of Boston Scientific Corporation (NYSE:BSX)
Trifecta Capital Advisors LLC grew its stake in shares of Boston Scientific Corporation (NYSE:BSX - Free Report) by 11.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 43,401 shares of the medica
Boston Scientific Corporation stock logo
CENTRAL TRUST Co Raises Stock Holdings in Boston Scientific Corporation (NYSE:BSX)
CENTRAL TRUST Co boosted its stake in shares of Boston Scientific Corporation (NYSE:BSX - Free Report) by 108.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,472 shares o
Boston Scientific (NYSE:BSX) Upgraded at Leerink Partnrs
Brokers Offer Predictions for BSX Q2 Earnings
Boston Scientific Corporation stock logo
Research Analysts Offer Predictions for BSX FY2025 Earnings
Boston Scientific Corporation (NYSE:BSX - Free Report) - Equities researchers at Leerink Partnrs issued their FY2025 earnings estimates for Boston Scientific in a report released on Monday, June 16th. Leerink Partnrs analyst M. Kratky expects that the medical equipment provider will earn $2.93 pe
Boston Scientific Corporation stock logo
State of Alaska Department of Revenue Has $17.42 Million Stock Position in Boston Scientific Corporation (NYSE:BSX)
State of Alaska Department of Revenue increased its position in shares of Boston Scientific Corporation (NYSE:BSX - Free Report) by 2.8% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 172,671 shares of the medical equipment provider's s
Boston Scientific Corporation stock logo
Wolf Group Capital Advisors Takes $2.14 Million Position in Boston Scientific Corporation (NYSE:BSX)
Wolf Group Capital Advisors bought a new position in shares of Boston Scientific Corporation (NYSE:BSX - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 21,255 shares of the medical equi
Boston Scientific Corporation stock logo
Clarius Group LLC Buys 2,968 Shares of Boston Scientific Corporation (NYSE:BSX)
Clarius Group LLC raised its stake in shares of Boston Scientific Corporation (NYSE:BSX - Free Report) by 34.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,493 shares of the medical equipment provider's stock afte
Boston Scientific Corporation stock logo
Boston Scientific Corporation (NYSE:BSX) Stock Position Lessened by Financial Perspectives Inc
Financial Perspectives Inc lowered its stake in shares of Boston Scientific Corporation (NYSE:BSX - Free Report) by 5.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 137,192 shares
Boston Scientific Corporation stock logo
Grimes & Company Inc. Lowers Position in Boston Scientific Corporation (NYSE:BSX)
Grimes & Company Inc. cut its position in shares of Boston Scientific Corporation (NYSE:BSX - Free Report) by 33.8% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,562 shares of the medical equipment
Boston Scientific Corporation stock logo
Janney Montgomery Scott LLC Acquires 78,301 Shares of Boston Scientific Corporation (NYSE:BSX)
Janney Montgomery Scott LLC grew its holdings in Boston Scientific Corporation (NYSE:BSX - Free Report) by 37.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 285,463 shares of the medical equipment provider's stock after acq
Leerink Partners Begins Coverage on Boston Scientific (NYSE:BSX)
I'm Buying Dividend Aristocrats At Bargain Basement Prices
Boston Scientific Corporation stock logo
Equities Analysts Offer Predictions for BSX Q2 Earnings
Boston Scientific Co. (NYSE:BSX - Free Report) - Analysts at Leerink Partnrs issued their Q2 2025 earnings estimates for shares of Boston Scientific in a research note issued on Monday, June 16th. Leerink Partnrs analyst M. Kratky forecasts that the medical equipment provider will post earnings p
Boston Scientific Corporation stock logo
Leerink Partnrs Upgrades Boston Scientific (NYSE:BSX) to Strong-Buy
Leerink Partnrs upgraded shares of Boston Scientific to a "strong-buy" rating in a report on Monday.
Boston Scientific Corporation stock logo
PKO Investment Management Joint Stock Co Acquires 3,000 Shares of Boston Scientific Co. (NYSE:BSX)
PKO Investment Management Joint Stock Co lifted its position in Boston Scientific Co. (NYSE:BSX - Free Report) by 30.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,000 shares
Boston Scientific Corporation stock logo
Insigneo Advisory Services LLC Purchases 2,906 Shares of Boston Scientific Co. (NYSE:BSX)
Insigneo Advisory Services LLC raised its position in Boston Scientific Co. (NYSE:BSX - Free Report) by 24.8% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,631 shares of the me
Boston Scientific Corporation stock logo
Boston Scientific Co. (NYSE:BSX) Shares Acquired by Chicago Capital LLC
Chicago Capital LLC lifted its stake in Boston Scientific Co. (NYSE:BSX - Free Report) by 144.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 497,991 shares of the medical equipment provider's stock after purchasing an additional 294,5
Boston Scientific Corporation stock logo
WD Rutherford LLC Has $871,000 Holdings in Boston Scientific Co. (NYSE:BSX)
WD Rutherford LLC increased its position in Boston Scientific Co. (NYSE:BSX - Free Report) by 63.7% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 9,245 shares of the medical equipment provider's stock after purchasing an additional 3,599 shares during th
Boston Scientific Corporation stock logo
Louisbourg Investments Inc. Has $861,000 Stake in Boston Scientific Co. (NYSE:BSX)
Louisbourg Investments Inc. reduced its stake in Boston Scientific Co. (NYSE:BSX - Free Report) by 35.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,530 shares of the medical equipment provider's st
Boston Scientific Corporation stock logo
Boston Scientific Co. (NYSE:BSX) Shares Acquired by QRG Capital Management Inc.
QRG Capital Management Inc. boosted its holdings in Boston Scientific Co. (NYSE:BSX - Free Report) by 47.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 164,362 shares of the medical equipment provider's stock after acquiring an additional 52,6
Boston Scientific Corporation stock logo
Trust Point Inc. Has $702,000 Holdings in Boston Scientific Co. (NYSE:BSX)
Trust Point Inc. lessened its stake in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 32.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 6,955 shares of the medical equipment provider's stock afte
Boston Scientific Corporation stock logo
Boston Scientific (NYSE:BSX) Earns Outperform Rating from Analysts at Leerink Partners
Leerink Partners began coverage on shares of Boston Scientific in a research note on Monday. They issued an "outperform" rating and a $118.00 target price on the stock.
Boston Scientific Corporation stock logo
Sowell Financial Services LLC Has $4.24 Million Stock Position in Boston Scientific Co. (NYSE:BSX)
Sowell Financial Services LLC lifted its stake in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 108.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 41,981 shares of the medical equipment provider's stock after buying
Boston Scientific Corporation stock logo
Cyndeo Wealth Partners LLC Purchases 4,383 Shares of Boston Scientific Co. (NYSE:BSX)
Cyndeo Wealth Partners LLC lifted its position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 11.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 43,284 shares of
Boston Scientific Corporation stock logo
Boston Scientific Co. (NYSE:BSX) Shares Bought by Bank Pictet & Cie Europe AG
Bank Pictet & Cie Europe AG raised its holdings in Boston Scientific Co. (NYSE:BSX - Free Report) by 28.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 93,901 shares of the medical equipment provider's stock after acquiring an additional 20,805 shares dur
Boston Scientific Corporation stock logo
Mn Services Vermogensbeheer B.V. Sells 38,400 Shares of Boston Scientific Co. (NYSE:BSX)
Mn Services Vermogensbeheer B.V. reduced its stake in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 6.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 540,300 shares of the medical equipment provide
Boston Scientific Corporation stock logo
Foster Victor Wealth Advisors LLC Has $17.17 Million Position in Boston Scientific Co. (NYSE:BSX)
Foster Victor Wealth Advisors LLC reduced its stake in Boston Scientific Co. (NYSE:BSX - Free Report) by 6.6% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 183,256 shares of the medical equipment provider's stock after selling 12,856 shares duri
Boston Scientific Corporation stock logo
22,473 Shares in Boston Scientific Co. (NYSE:BSX) Bought by Azzad Asset Management Inc. ADV
Azzad Asset Management Inc. ADV bought a new stake in Boston Scientific Co. (NYSE:BSX - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 22,473 shares of the medical equ
Boston Scientific Corporation stock logo
Boston Scientific Co. (NYSE:BSX) Holdings Decreased by Elevation Point Wealth Partners LLC
Elevation Point Wealth Partners LLC trimmed its position in Boston Scientific Co. (NYSE:BSX - Free Report) by 21.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,156 shares of the medical equipment provider's stock after
Boston Scientific Corporation stock logo
Robbins Farley Purchases Shares of 37,080 Boston Scientific Co. (NYSE:BSX)
Robbins Farley purchased a new stake in shares of Boston Scientific Co. (NYSE:BSX - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 37,080 shares of the medical equipment provider's stock, valued at approxima
Boston Scientific Corporation stock logo
Tobam Cuts Position in Boston Scientific Co. (NYSE:BSX)
Tobam decreased its position in Boston Scientific Co. (NYSE:BSX - Free Report) by 71.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,191 shares of the medical equipment provider's st
Boston Scientific Corporation stock logo
Salem Investment Counselors Inc. Cuts Stock Holdings in Boston Scientific Co. (NYSE:BSX)
Salem Investment Counselors Inc. lowered its position in Boston Scientific Co. (NYSE:BSX - Free Report) by 2.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 192,846 shares of the medical equipment p
Boston Scientific Corporation stock logo
Aubrey Capital Management Ltd Has $4.44 Million Stock Position in Boston Scientific Co. (NYSE:BSX)
Aubrey Capital Management Ltd reduced its position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 13.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,000 shares
Boston Scientific Corporation stock logo
Boston Scientific Co. (NYSE:BSX) Shares Acquired by Fifth Third Bancorp
Fifth Third Bancorp increased its position in Boston Scientific Co. (NYSE:BSX - Free Report) by 18.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 271,489 shares of the medical equipment provider's stock after purchasing an
Boston Scientific Corporation stock logo
Union Bancaire Privee UBP SA Sells 143,812 Shares of Boston Scientific Co. (NYSE:BSX)
Union Bancaire Privee UBP SA cut its holdings in shares of Boston Scientific Co. (NYSE:BSX - Free Report) by 37.6% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 238,681 shares of the medical equipment provider's stock after sell
Boston Scientific Corporation stock logo
McElhenny Sheffield Capital Management LLC Purchases New Shares in Boston Scientific Co. (NYSE:BSX)
McElhenny Sheffield Capital Management LLC acquired a new position in Boston Scientific Co. (NYSE:BSX - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 5,094 shares of the medical equipment
Boston Scientific Corporation stock logo
Boston Scientific (NYSE:BSX) Updates Q2 2025 Earnings Guidance
Boston Scientific (NYSE:BSX) updated its second quarter 2025 earnings guidance. The company provided EPS guidance of 0.710-0.730 for the period, compared to the consensus estimate of 0.710. The company also issued revenue guidance of $4.8 billionillion-$4.9 billionillion, compared to the consensus estimate of $4.9 billionillion.
Boston Scientific Corporation stock logo
Boston Scientific (NYSE:BSX) Updates FY 2025 Earnings Guidance
Boston Scientific (NYSE:BSX) updated its FY 2025 earnings guidance. The company provided EPS guidance of 2.870-2.940 for the period, compared to the consensus estimate of 2.880. The company also issued revenue guidance of $19.3 billionillion-$19.6 billionillion, compared to the consensus estimate of $19.5 billionillion.
Boston Scientific Corporation stock logo
Arvest Investments Inc. Invests $1.31 Million in Boston Scientific Co. (NYSE:BSX)
Arvest Investments Inc. purchased a new position in Boston Scientific Co. (NYSE:BSX - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 12,937 shares of the medical equipment provider's stock, valued at appro
Boston Scientific Corporation stock logo
Sanibel Captiva Trust Company Inc. Takes Position in Boston Scientific Co. (NYSE:BSX)
Sanibel Captiva Trust Company Inc. purchased a new stake in Boston Scientific Co. (NYSE:BSX - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 3,953 shares of the medical equipment provider'
Boston Scientific Corporation stock logo
Harbor Capital Advisors Inc. Sells 25,443 Shares of Boston Scientific Co. (NYSE:BSX)
Harbor Capital Advisors Inc. trimmed its holdings in Boston Scientific Co. (NYSE:BSX - Free Report) by 54.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 21,580 shares of the medical equipment provider's stock after selling
Boston Scientific Corporation stock logo
Boston Scientific Co. (NYSE:BSX) Receives Consensus Recommendation of "Buy" from Analysts
Boston Scientific Co. (NYSE:BSX - Get Free Report) has been assigned an average rating of "Buy" from the twenty-two brokerages that are presently covering the company, Marketbeat.com reports. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating
Get Boston Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter.

BSX Media Mentions By Week

BSX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BSX
News Sentiment

1.14

0.69

Average
Medical
News Sentiment

BSX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BSX Articles
This Week

50

26

BSX Articles
Average Week

Get Boston Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:BSX) was last updated on 6/20/2025 by MarketBeat.com Staff
From Our Partners